Tissue Sectioning Market Competitive Landscape 2024-2033 – Major Players and Strategies

Overview and Scope

The tissue sectioning market consists of revenues earned by entities by providing services such as tissue processing, microtomy, staining, and slide preparation. The market value includes the value of related goods sold by the service provider or included within the service offering. The tissue sectioning market also includes sales of microtome, paraffin dispenser, water bath, and section mounting equipment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Sizing and Forecast

The tissue sectioning market size has grown strongly in recent years. It will grow from $0.69 billion in 2023 to $0.76 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases, growing aging population, rising investments in life sciences research, expanding biotechnology and pharmaceutical industries, government initiatives supporting research, rising demand for companion diagnostics, increasing awareness about early disease detection, growth in regenerative medicine.

The tissue sectioning market size is expected to see strong growth in the next few years. It will grow to $1.11 billion in 2028 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to demand for personalized medicine, growth in biobanks, investments in research and development, increasing healthcare expenditure, growing awareness about early disease detection, emergence of digital pathology, rising demand for biomarker discovery, growing biopharmaceutical industry, rising demand for point of care testing. Major trends in the forecast period include advancements in automation technology, integration of ai and machine learning, digital pathology integration, adoption of 3d tissue sectioning techniques, development of high throughput solutions, expansion of research applications, development of novel cutting techniques, advancements in imaging modalities, adoption of cryosectioning techniques.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/tissue-sectioning-global-market-report

Segmentation & Regional Insights

The tissue sectioning market covered in this report is segmented –

1) By Product: Accessories And Consumables, Instruments, Services
2) By Technology: Automatic, Manual, Semi-Automatic
3) By Application: Diagnosis, Research
4) By End-User: Clinics, Diagnostic Laboratories, Hospitals, Research Centers

North America was the largest region in the tissue sectioning market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tissue sectioning market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16555&type=smp

Major Driver Impacting Market Growth

The rising surgical procedures are expected to propel the growth of the tissue sectioning market going forward. Surgical procedures are medical interventions involving instruments to diagnose, treat, or repair the body. The rise in surgical procedures is due to advancements in medical technology, demographic changes, and shifts in healthcare practices. Tissue sectioning aids surgical procedures by providing precise, thin tissue slices for histological analysis, enabling accurate diagnosis, treatment planning, and transplantation. For instance, in December 2023, according to the Australian Institute of Health and Welfare (AIHW), an Australia-based government agency for public health and welfare, in 2022–23, there were 735,500 patients admitted for surgery from public hospital elective surgery waiting lists, marking an 18% rise from 2021–22. Therefore, rising surgical procedures are driving the tissue sectioning market.

Key Industry Players

Major companies operating in the tissue sectioning market are Thermo Fisher Scientific Inc., Danaher Corporation, Labcorp Drug Development, Agilent Technologies Inc., Leica Biosystems Nussloch GmbH, Abcam Limited, Sakura Finetek USA Inc., Ted Pella Inc., Santa Cruz Biotechnology Inc., Milestone Srl, Diapath S.p.A., Bio-Optica Milano S.p.A, MEDITE Medical GmbH, PathnSitu Biotechnologies Pvt Ltd, Tanner Scientific Inc., Boeckeler Instruments Inc., SLEE Medical GmbH, Amos Scientific PTY. LTD., LLS ROWIAK LaserLabSolutions GmbH, SM Scientific Instruments Pvt. Ltd., Bright Instrument Co. Ltd., RWD Life Science Co. Ltd., Hacker Instruments & Industries Inc.

The tissue sectioning market report table of contents includes:

1. Executive Summary
2. Tissue Sectioning Market Characteristics
3. Tissue Sectioning Market Trends And Strategies
4. Tissue Sectioning Market – Macro Economic Scenario
5. Global Tissue Sectioning Market Size and Growth
.
.
.
32. Global Tissue Sectioning Market Competitive Benchmarking
33. Global Tissue Sectioning Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Tissue Sectioning Market
35. Tissue Sectioning Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model